Hikma Pharmaceuticals PLC
Closed
SectorHealthcare
1,486 -1.78
Overview
Share price change
24h
Min
1490
Max
1572
Income | 165M |
|---|---|
Sales | 1.7B |
P/E Sector Avg | 11.394 60.549 |
Dividend yield | 5.44 |
Profit margin | 9.698 |
Employees | 9,400 |
EBITDA | 411M |
Recommendations | Buy |
|---|---|
12 Months Forecast | +10.71% upside |
Dividend yield Sector Avg | 5.44% 2.22% |
|---|---|
Next Earnings | 6 sie 2026 |
Next Dividend date | 17 wrz 2026 |
Next Ex Dividend date | 13 sie 2026 |
Market Cap | 3.3B |
|---|---|
Previous open | 1487.78 |
Previous close | 1486 |
News Sentiment
By Acuity
23%
77%
71 / 342 Ranking in Healthcare
Hikma Pharmaceuticals PLC Chart
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
Related News
Peer Comparison
Price change
Hikma Pharmaceuticals PLC Forecast
Price Target
By TipRanks
12 Months Forecast
Average 1,742.5 GBX 10.71%
High 1,950 GBX
Low 1,350 GBX
Based on 4 Wall Street analysts offering 12 month price targets forHikma Pharmaceuticals PLC - Dist in the last 3 months.
Sentiment
By Acuity
News Sentiment
Very Strong Bullish Evidence
Volatility
Below average
News Volume (RCV)
Below average
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$